Certara (CERT) announced the appointment of Christopher Bouton as CTO. In this role, Bouton will lead technology strategy and development of a next-generation integrated model-informed drug development platform, which is enabled by generative AI and advances in biosimulation technology. Bouton was the founder and CEO of Vyasa Analytics, acquired by Certara in 2022.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CERT: